fluorexon has been researched along with Bone Fractures in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ji, Y; Liu, N; Wang, Y; Wu, Y; Xie, H; Yan, J; Yang, J; Zhang, N; Zhao, D; Zhou, C; Zhuang, J | 1 |
| Alman, BA; Amani, Y; Baht, GS; Nadesan, P; Silkstone, D; Vi, L; Wei, Q; Whetstone, H | 1 |
| Anderson, DE; Bertone, AL; Rohde, C; Weisbrode, SE | 1 |
3 other study(ies) available for fluorexon and Bone Fractures
| Article | Year |
|---|---|
Assessment of the degradation rates and effectiveness of different coated Mg-Zn-Ca alloy scaffolds for in vivo repair of critical-size bone defects.
Topics: Alloys; Animals; Biocompatible Materials; Biomechanical Phenomena; Bone and Bones; Calcium; Female; Fluoresceins; Fractures, Bone; Gases; Hydrogen; Magnesium; Male; Minerals; Osteogenesis; Rabbits; Reproducibility of Results; Stress, Mechanical; Tissue Scaffolds; Ulna; X-Ray Microtomography; X-Rays; Zinc | 2018 |
Exposure to a youthful circulaton rejuvenates bone repair through modulation of β-catenin.
Topics: Alleles; Animals; beta Catenin; Binding Sites; Bone and Bones; Bone Marrow; Cell Differentiation; Culture Media, Conditioned; Female; Fluoresceins; Fracture Healing; Fractures, Bone; Hematopoietic Stem Cells; Mesenchymal Stem Cells; Mice; Mice, Transgenic; Osteoblasts; Osteogenesis; Parabiosis; Phenotype; Regeneration; Signal Transduction; Tibia; Time Factors; Wnt Proteins | 2015 |
Effects of phenylbutazone on bone activity and formation in horses.
Topics: Alkaline Phosphatase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Bone Density; Bone Remodeling; Chromatography, High Pressure Liquid; Female; Fluoresceins; Fluorescent Dyes; Fracture Healing; Fractures, Bone; Haversian System; Horse Diseases; Horses; Image Processing, Computer-Assisted; Immunoassay; Male; Oxytetracycline; Phenylbutazone; Prostaglandin Antagonists; Random Allocation; Tibia | 2000 |